Literature DB >> 22195750

Innate and adaptive interferons suppress IL-1α and IL-1β production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection.

Katrin D Mayer-Barber1, Bruno B Andrade, Daniel L Barber, Sara Hieny, Carl G Feng, Patricia Caspar, Sandy Oland, Siamon Gordon, Alan Sher.   

Abstract

Interleukin-1 (IL-1) receptor signaling is necessary for control of Mycobacterium tuberculosis (Mtb) infection, yet the role of its two ligands, IL-1α and IL-1β, and their regulation in vivo are poorly understood. Here, we showed that both IL-1α and IL-1β are critically required for host resistance and identified two multifunctional inflammatory monocyte-macrophage and DC populations that coexpressed both IL-1 species at the single-cell level in lungs of Mtb-infected mice. Moreover, we demonstrated that interferons (IFNs) played important roles in regulating IL-1 production by these cells in vivo. Type I interferons inhibited IL-1 production by both subsets whereas CD4(+) T cell-derived IFN-γ selectively suppressed monocyte-macrophages. These data provide a cellular basis for both the anti-inflammatory effects of IFNs and probacterial functions of type I IFNs during Mtb infection and reveal differential regulation of IL-1 production by distinct cell populations as an additional layer of complexity in the activity of IL-1 in vivo.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22195750      PMCID: PMC3246221          DOI: 10.1016/j.immuni.2011.12.002

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  48 in total

Review 1.  Immunology of tuberculosis.

Authors:  J L Flynn; J Chan
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

2.  Interferons as inhibitors of interleukin 1 induced interleukin 1 synthesis.

Authors:  R Schindler; P Ghezzi; C A Dinarello
Journal:  Lymphokine Res       Date:  1989

3.  Homeostatic role of interferons conferred by inhibition of IL-1-mediated inflammation and tissue destruction.

Authors:  Xiaoyu Hu; Hao H Ho; Olivia Lou; Chisa Hidaka; Lionel B Ivashkiv
Journal:  J Immunol       Date:  2005-07-01       Impact factor: 5.422

4.  Hypervirulent M. tuberculosis W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway.

Authors:  Claudia Manca; Liana Tsenova; Sherry Freeman; Amy K Barczak; Michael Tovey; Peter J Murray; Clifton Barry; Gilla Kaplan
Journal:  J Interferon Cytokine Res       Date:  2005-11       Impact factor: 2.607

5.  Mycobacterium tuberculosis triggers host type I IFN signaling to regulate IL-1β production in human macrophages.

Authors:  Aleksey Novikov; Marco Cardone; Robert Thompson; Kevin Shenderov; Kevin D Kirschman; Katrin D Mayer-Barber; Timothy G Myers; Ronald L Rabin; Giorgio Trinchieri; Alan Sher; Carl G Feng
Journal:  J Immunol       Date:  2011-07-22       Impact factor: 5.422

6.  Induction of circulating IL-1 receptor antagonist by IFN treatment.

Authors:  H Tilg; J W Mier; W Vogel; W E Aulitzky; C J Wiedermann; E Vannier; C Huber; C A Dinarello
Journal:  J Immunol       Date:  1993-05-15       Impact factor: 5.422

7.  T cell-derived tumour necrosis factor is essential, but not sufficient, for protection against Mycobacterium tuberculosis infection.

Authors:  B M Saunders; H Briscoe; W J Britton
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

8.  In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice.

Authors:  Joanne Turner; Mercedes Gonzalez-Juarrero; Debi L Ellis; Randy J Basaraba; Andre Kipnis; Ian M Orme; Andrea M Cooper
Journal:  J Immunol       Date:  2002-12-01       Impact factor: 5.422

9.  TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection.

Authors:  Natalya V Serbina; Thais P Salazar-Mather; Christine A Biron; William A Kuziel; Eric G Pamer
Journal:  Immunity       Date:  2003-07       Impact factor: 31.745

Review 10.  Immunity to tuberculosis.

Authors:  Robert J North; Yu-Jin Jung
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

View more
  196 in total

Review 1.  Type I IFN-mediated regulation of IL-1 production in inflammatory disorders.

Authors:  Kristina Ludigs; Valeriy Parfenov; Renaud A Du Pasquier; Greta Guarda
Journal:  Cell Mol Life Sci       Date:  2012-04-24       Impact factor: 9.261

2.  The impact of ISGylation during Mycobacterium tuberculosis infection in mice.

Authors:  Jacqueline M Kimmey; Jessica A Campbell; Leslie A Weiss; Kristen J Monte; Deborah J Lenschow; Christina L Stallings
Journal:  Microbes Infect       Date:  2017-01-10       Impact factor: 2.700

3.  Cutting edge: Mycobacterium tuberculosis but not nonvirulent mycobacteria inhibits IFN-β and AIM2 inflammasome-dependent IL-1β production via its ESX-1 secretion system.

Authors:  Swati Shah; Amro Bohsali; Sarah E Ahlbrand; Lalitha Srinivasan; Vijay A K Rathinam; Stefanie N Vogel; Katherine A Fitzgerald; Fayyaz S Sutterwala; Volker Briken
Journal:  J Immunol       Date:  2013-08-30       Impact factor: 5.422

4.  Coexistent Malnutrition Is Associated with Perturbations in Systemic and Antigen-Specific Cytokine Responses in Latent Tuberculosis Infection.

Authors:  Rajamanickam Anuradha; Saravanan Munisankar; Yukthi Bhootra; Nathalla Pavan Kumar; Chandrakumar Dolla; Paul Kumaran; Subash Babu
Journal:  Clin Vaccine Immunol       Date:  2016-04-04

5.  Interdependence between Interleukin-1 and Tumor Necrosis Factor Regulates TNF-Dependent Control of Mycobacterium tuberculosis Infection.

Authors:  Nelson C Di Paolo; Shahin Shafiani; Tracey Day; Thalia Papayannopoulou; Thalia Papayannoupoulou; David W Russell; Yoichiro Iwakura; David Sherman; Kevin Urdahl; Dmitry M Shayakhmetov
Journal:  Immunity       Date:  2015-12-15       Impact factor: 31.745

6.  Changes in inflammatory protein and lipid mediator profiles persist after antitubercular treatment of pulmonary and extrapulmonary tuberculosis: A prospective cohort study.

Authors:  Caian L Vinhaes; Deivide Oliveira-de-Souza; Paulo S Silveira-Mattos; Betania Nogueira; Ruiru Shi; Wang Wei; Xing Yuan; Guolong Zhang; Ying Cai; Clifton E Barry; Laura E Via; Kiyoshi F Fukutani; Bruno B Andrade; Katrin D Mayer-Barber
Journal:  Cytokine       Date:  2019-06-18       Impact factor: 3.861

Review 7.  Striking the right immunological balance prevents progression of tuberculosis.

Authors:  Shachi Pranjal Vyas; Ritobrata Goswami
Journal:  Inflamm Res       Date:  2017-07-15       Impact factor: 4.575

8.  Intravascular staining for discrimination of vascular and tissue leukocytes.

Authors:  Kristin G Anderson; Katrin Mayer-Barber; Heungsup Sung; Lalit Beura; Britnie R James; Justin J Taylor; Lindor Qunaj; Thomas S Griffith; Vaiva Vezys; Daniel L Barber; David Masopust
Journal:  Nat Protoc       Date:  2014-01-02       Impact factor: 13.491

9.  Nontransformed, GM-CSF-dependent macrophage lines are a unique model to study tissue macrophage functions.

Authors:  György Fejer; Mareike Dorothee Wegner; Ildiko Györy; Idan Cohen; Peggy Engelhard; Elena Voronov; Thomas Manke; Zsolt Ruzsics; Lars Dölken; Olivia Prazeres da Costa; Nora Branzk; Michael Huber; Antje Prasse; Robert Schneider; Ron N Apte; Chris Galanos; Marina A Freudenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-24       Impact factor: 11.205

10.  Autophagy protects against active tuberculosis by suppressing bacterial burden and inflammation.

Authors:  Eliseo F Castillo; Alexander Dekonenko; John Arko-Mensah; Michael A Mandell; Nicolas Dupont; Shanya Jiang; Monica Delgado-Vargas; Graham S Timmins; Dhruva Bhattacharya; Hongliang Yang; Julie Hutt; C Rick Lyons; Karen M Dobos; Vojo Deretic
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.